肺移植术中常规与按需体外膜氧合随机试验:可行性研究
该前瞻性单中心随机对照试验筛选所有肺移植患者,排除再移植、多器官移植及必须使用ECMO者,旨在评估比较常规与选择性VA-ECMO方案的可行性。研究设定6个月内招募19例且方案违背率低于10%为可行标准,结论认为该方案可行且安全,支持开展多中心试验。
要点
- 比较肺移植术中常规与选择性VA-ECMO的随机方案可行且安全。
- 可行性标准为6个月招募19例且方案违背率低于10%。
- 结果为开展多中心试验提供了依据,招募失败风险低。
核心结论
- 基于完成的可行性研究,该方案可行且安全,支持开展多中心试验且因招募不足而失败的风险低。
研究设计与样本
- 前瞻性单中心随机对照试验,筛选所有接受肺移植的患者。
- 排除标准包括再移植、多器官移植以及必须使用ECMO的病例。
- 可行性标准为6个月内招募19例参与者且方案违背率低于10%。
主要发现
- 研究判定该试验可行,满足6个月招募19例且方案违背率低于10%的标准。
关键数值与推荐
- 可行性阈值:6个月内招募19例参与者。
- 可行性阈值:方案违背率低于10%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In most centers, extracorporeal membrane oxygenation (ECMO) is the preferred means to provide cardiopulmonary support during lung transplantation. However, there is controversy about whether intraoperative venoarterial (VA) ECMO should be used routinely or selectively. A randomized controlled trial is the best way to address this controversy. In this publication, we describe a feasibility study to assess the practicality of a protocol comparing routine versus selective VA-ECMO during lung transplantation. This prospective, single-center, randomized controlled trial screened all patients undergoing lung transplantation. Exclusion criteria include retransplantation, multiorgan transplantation, and cases where ECMO is mandatory. We determined that the trial would be feasible if we could recruit 19 participants over 6 months with less than 10% protocol violations. Based on the completed feasibility study, we conclude that the protocol is feasible and safe, giving us the impetus to pursue a multicenter trial with little risk of failure due to low recruitment.
引用
- Nasir BS, Weatherald J, Ramsay T, et al. Randomized trial of routine versus on-demand intraoperative extracorporeal membrane oxygenation in lung transplantation: A feasibility study. J Heart Lung Transplant. 2024. PMID: 38423414. doi:10.1016/j.healun.2024.02.1454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。